- Patent Title: Sphingosine kinase 2 inhibitor for treating coronavirus infection
-
Application No.: US17502932Application Date: 2021-10-15
-
Publication No.: US11364227B2Publication Date: 2022-06-21
- Inventor: Dror Ben-Asher , Reza Fathi
- Applicant: RedHill Biopharma Ltd.
- Applicant Address: IL Tel-Aviv
- Assignee: RedHill Biopharma Ltd.
- Current Assignee: RedHill Biopharma Ltd.
- Current Assignee Address: IL Tel-Aviv
- Agency: Greenberg Traurig, LLP
- Main IPC: A61K31/4409
- IPC: A61K31/4409 ; A61P31/14 ; A61K9/00 ; A61K9/48 ; A61K31/435 ; A61M31/00
Abstract:
The disclosure is directed to ABC294640, as free base or as salts thereof, in preparing medicines for treating coronavirus infection or preventing diseases caused by coronavirus infection, and a medicine for preventing coronavirus infection or preventing diseases caused by coronavirus infection.
Public/Granted literature
- US20220031682A1 SPHINGOSINE KINASE 2 INHIBITOR FOR TREATING CORONAVIRUS INFECTION Public/Granted day:2022-02-03
Information query
IPC分类:
